Jan. 7, 2021
Rochester, Minn.― Mayo Clinic Laboratories and American Hospital Dubai announce a strategic partnership aimed at improving advanced laboratory diagnostics in the Dubai region. Under the agreement, the two organizations will begin delivering laboratory testing through a collaboration based out of American Hospital Dubai in early 2021.
“Our goal for this relationship is to offer advanced laboratory testing to better help clinicians answer complex medical questions for their patients,” says William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories. “Effective laboratory diagnostics is critical to improving patient care, and, by bringing this service straight to the region, we are dramatically reducing test turnaround times.”
Mayo Clinic Laboratories and American Hospital Dubai also will work together to improve access to complex laboratory diagnostics for the region’s providers. By improving access to laboratory testing, health care providers will have the necessary tools to advance patient care.
“Laboratory medicine is an essential foundation for patient care, and without it, providers are not able to provide their patients with accurate and timely answers. Both our organizations are dedicated to building this foundation for the patients in the region,” says Mohamed Salama, M.D., chief medical officer for Mayo Clinic Laboratories.
“We are excited to build upon the knowledge of Mayo Clinic Laboratories to deliver practice-defining diagnostics in the region,” says Sherif Beshara, Group CEO of American Hospital Dubai. Under the agreement, testing will be performed either at American Hospital Dubai or a Mayo Clinic Laboratories facility.
About Mayo Clinic Laboratories
Mayo Clinic Laboratories is the reference laboratory for Mayo Clinic and provides advanced laboratory testing and pathology services to support 4,000 health care organizations around the world. Revenue from this testing supports medical education and research at Mayo Clinic, a nonprofit worldwide leader in medical care, research and education for people from all walks of life. Complemented by collaborations with diagnostic and biotechnology companies, the department maintains a robust diagnostic test-development program, launching more than 120 new tests each year.
Suzanne Ferguson, Mayo Clinic Laboratories, 507-284-5005, firstname.lastname@example.org